Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Ries

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2006
Quantitative dysmorphology assessment in Fabry diseaseMarkus Ries, David F Moore, Chevalia J Robinson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry diseaseDavid F Moore, Ehud Goldin, Monique P Gelderman, et al.
Journal of Inherited Metabolic Disease|September 15, 2006
Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and CMarkus Ries, Ellen Schaefer, Till Lührs, et al.
Muscle & Nerve|April 4, 2006
Enzyme replacement therapy and intraepidermal innervation density in Fabry diseaseRaphael Schiffmann, Peter Hauer, Barbara Freeman, et al.
Autophagy|November 24, 2021
Quantitative retrospective natural history modeling of <i>WDR45</i>-related developmental and epileptic encephalopathy - a systematic cross-sectional analysis of 160 published casesAfshin Saffari, Julian Schröter, Sven F Garbade, et al.
BMC Neurology|November 8, 2008
Skin-impedance in Fabry Disease: a prospective, controlled, non-randomized clinical studySurya N Gupta, Markus Ries, Gary J Murray, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2007
Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalitiesDavid F Moore, Oleg V Krokhin, Ronald C Beavis, et al.
Optics Express|August 10, 2017
Enhancing the sensitivity of nano-FTIR spectroscopyPeter Hermann, Bernd Kästner, Arne Hoehl, et al.
The Journal of Pediatrics|January 26, 2010
Four-year prospective clinical trial of agalsidase alfa in children with Fabry diseaseRaphael Schiffmann, Rick A Martin, Tyler Reimschisel, et al.
Journal of Inherited Metabolic Disease|August 27, 2020
Quantitative retrospective natural history modeling for orphan drug developmentSven F Garbade, Matthias Zielonka, Shoko Komatsuzaki, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 17, 2006
Quantitative dysmorphology assessment in Fabry diseaseMarkus Ries, David F Moore, Chevalia J Robinson, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry diseaseDavid F Moore, Ehud Goldin, Monique P Gelderman, et al.
Journal of Inherited Metabolic Disease|September 15, 2006
Critical assessment of chitotriosidase analysis in the rational laboratory diagnosis of children with Gaucher disease and Niemann-Pick disease type A/B and CMarkus Ries, Ellen Schaefer, Till Lührs, et al.
Muscle & Nerve|April 4, 2006
Enzyme replacement therapy and intraepidermal innervation density in Fabry diseaseRaphael Schiffmann, Peter Hauer, Barbara Freeman, et al.
Autophagy|November 24, 2021
Quantitative retrospective natural history modeling of <i>WDR45</i>-related developmental and epileptic encephalopathy - a systematic cross-sectional analysis of 160 published casesAfshin Saffari, Julian Schröter, Sven F Garbade, et al.
BMC Neurology|November 8, 2008
Skin-impedance in Fabry Disease: a prospective, controlled, non-randomized clinical studySurya N Gupta, Markus Ries, Gary J Murray, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 16, 2007
Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalitiesDavid F Moore, Oleg V Krokhin, Ronald C Beavis, et al.
Optics Express|August 10, 2017
Enhancing the sensitivity of nano-FTIR spectroscopyPeter Hermann, Bernd Kästner, Arne Hoehl, et al.
The Journal of Pediatrics|January 26, 2010
Four-year prospective clinical trial of agalsidase alfa in children with Fabry diseaseRaphael Schiffmann, Rick A Martin, Tyler Reimschisel, et al.
Journal of Inherited Metabolic Disease|August 27, 2020
Quantitative retrospective natural history modeling for orphan drug developmentSven F Garbade, Matthias Zielonka, Shoko Komatsuzaki, et al.
Pageof 10